仿生脑肿瘤微环境调控胶质母细胞瘤细胞向癌症干细胞表型转化
研究以琼脂糖与羟丙基甲基纤维素(HMC)构建不同浓度的水凝胶培养系统,模拟脑肿瘤微环境。人胶质母细胞瘤U-87 MG细胞在2.5% HMC-琼脂糖系统中培养4天形成的球体数量与尺寸最大,培养6天后CD133表达为60%,高于对照组的15%,且对替莫唑胺的耐药性最高。
要点
- 2.5% HMC-琼脂糖培养系统形成的球体数量与尺寸最大。
- 2.5% HMC-琼脂糖系统培养6天后CD133表达为60%,对照组为15%。
- 2.5% HMC-琼脂糖系统细胞在500 µM替莫唑胺作用72小时后活细胞比例仍>80%。
核心结论
- 仿生脑肿瘤微环境可调控胶质母细胞瘤细胞向癌症干细胞表型转化并表达癌症干细胞特征。
- HMC-琼脂糖培养系统中的微环境选择与球体形成可能为未来生物医学应用提供无标记的癌症干细胞筛选策略和药物测试模型。
研究设计与样本
- 建立由琼脂糖和羟丙基甲基纤维素(HMC)以不同浓度组成的水凝胶材料,在无标记系统中模拟脑肿瘤微环境和癌症干细胞微环境。
- 将人胶质母细胞瘤细胞系U-87 MG在系列HMC-琼脂糖培养系统中培养,培养4天后检测细胞聚集与球体形成,培养6天后检测CD133表达,并检测替莫唑胺作用72小时后的活细胞比例及ABCG2基因表达。
主要发现
- 培养4天后,2.5% HMC-琼脂糖培养系统形成的球体数量和尺寸最大。
- 培养6天后,2.5% HMC-琼脂糖培养系统中胶质母细胞瘤细胞CD133表达为60%,对照组仅为15%。
- 2.5% HMC-琼脂糖培养系统的细胞耐药性最高,即使在500 µM替莫唑胺作用72小时的高剂量下,活细胞比例仍>80%。
- 在2.5% HMC-琼脂糖培养系统培养后ABCG2基因表达上调。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glioblastoma (GBM) is the most malignant primary brain tumor and contains tumorigenic cancer stem cells (CSCs), which support the progression of tumor growth. The selection of CSCs and facilitation of the brain tumor niches may assist the development of novel therapeutics for GBM. Herein, hydrogel materials composed of agarose and hydroxypropyl methyl cellulose (HMC) in different concentrations were established and compared to emulate brain tumor niches and CSC microenvironments within a label-free system. Human GBM cell line, U-87 MG, was cultured on a series of HMC-agarose based culture system. Cell aggregation and spheroids formation were investigated after 4 days of culture, and 2.5% HMC-agarose based culture system demonstrated the largest spheroids number and size. Moreover, CD133 marker expression of GBM cells after 6 days of culture in 2.5% HMC-agarose based culture system was 60%, relatively higher than the control group at only 15%. Additionally, cells on 2.5% HMC-agarose based culture system show the highest chemoresistance, even at the high dose of 500 µM temozolomide for 72 h, the live cell ratio was still > 80%. Furthermore, the results also indicate that the expression of ABCG2 gene was up-regulated after culture in 2.5% HMC-agarose based culture system. Therefore, our results demonstrated that biomimetic brain tumor microenvironment may regulate GBM cells towards the CSC phenotype and expression of CSC characteristics. The microenvironment selection and spheroids formation in HMC-agarose based culture system may provide a label-free CSC selection strategy and drug testing model for future biomedical applications.
引用
- Liu YC, Lee IC, Chen PY, et al. Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype. J Neurooncol. 2018. PMID: 29357090. doi:10.1007/s11060-018-2763-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。